{
  "docId": "019dd923-622c-750b-8b98-916758668d1f",
  "docSlug": "34401c2968d1",
  "documentTitle": "Dexcom, Inc. (DXCM)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Ben Axler",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2019-03-21 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 83,
  "pageCount": 83,
  "prevPage": 82,
  "nextPage": null,
  "slideType": "valuation_table",
  "function": "show_valuation_bridge",
  "density": "balanced",
  "nDataPoints": 24,
  "notes": "The slide uses a standard valuation bridge format to derive equity value from enterprise value, adjusting for debt, cash, and equity investments.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "valuation_table"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b98-916758668d1f/83",
  "deckHref": "/decks/019dd923-622c-750b-8b98-916758668d1f",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b98-916758668d1f.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-916758668d1f#slide-83",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "We see ~45-60% near-term downside in DXCM as the U.S. T1 market is increasingly exhausted, as Dexcom fails to participate in the growth of the U.S. T2 CGM market, and as the release of the Libre 2 brings downward pricing pressure on the industry.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-f5d2-7501-bd8f-622ebd83856a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Price per Share: $64.14",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-f5d2-7501-bd8f-646d224e01dc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.9,
        "x": 0.05,
        "y": 0.16
      },
      "kind": "paragraph",
      "text": "We see ~45-60% near-term downside in DXCM as the U.S. T1 market is increasingly exhausted, as Dexcom fails to participate in the growth of the U.S. T2 CGM market, and as the release of the Libre 2 brings downward pricing pressure on the industry.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b361ecdb-af01-4a87-b0e7-ae5e5fc60d19",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.7,
        "x": 0.15,
        "y": 0.35
      },
      "kind": "table",
      "text": "Valuation bridge table showing FY20 Revenue, Multiple, Enterprise Value, adjustments for Net Debt, and final Price per Share/Downside.",
      "attrs": null,
      "subkind": "valuation",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4ea37c9e-cfe1-454d-8e6f-c061930701ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.68,
        "x": 0.28,
        "y": 0.03
      },
      "kind": "title",
      "text": "Spruce Point Sees 45-60% Near-Term Downside In DXCM Shares, With Significant Longer-Term Tail Risk",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4332a254-dedb-42c0-bfd2-f6f60f2a7fd8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "valuation-bridge",
      "slug": null,
      "matchId": "f182fdb6-f9de-4be8-b2d1-5c2313c2957f",
      "evidence": "The table structure follows a standard enterprise-to-equity value bridge.",
      "confidence": 0.95
    }
  ],
  "arcBeats": [
    {
      "to": 83,
      "from": 80,
      "beatId": "51756e2e-3d7b-4dc8-9e14-49d2b6c6c807",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": null,
      "evidence": "The deck concludes with a victory, where Spruce Point presents its conclusion of a near-term downside risk in DXCM shares.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}